Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker
Yamano, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 999-1002
1990
ISSN/ISBN: 0047-1852 PMID: 1693989 Document Number: 351660
Document emailed within 1 workday
Related Documents
Kawakita, T.; Shiraki, K.; Yamanaka, Y.; Yamaguchi, Y.; Saitou, Y.; Enokimura, N.; Yamamoto, N.; Okano, H.; Sugimoto, K.; Murata, K.; Yamakado, K.; Takeda, K.; Nakano, T. 2003: A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma International Journal of Oncology 23(4): 1115-1120Izuno, K.; Fujiyama, S.; Yamasaki, K.; Sato, M.; Sato, T. 1995: Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study Hepato-Gastroenterology 42(4): 387-393
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Hara, K.; Mitsuhashi, F.; Ohkura, H. 1990: Clinical significance of CA 50 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 971-973
Kimura, T.; Nawata, H. 1990: Clinical significance of elastase 1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 899-902
Kubota, S. 1990: Clinical significance of polyamine assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 953-956
Kato, H. 1990: Clinical significance of SCC antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1057-1059
Endo, J.; Nagaoka, S.; Kannagi, R. 1990: Clinical significance of sialyl SSEA-1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1008-1012
Fujino, M.; Endo, Y. 1990: Clinical significance of carcinoembryonic antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 907-911
Kuriyama, M.; Takahashi, Y.; Kawada, Y. 1990: Clinical significance of prostatic acid phosphatase assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 925-927
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945
Yamashiki, M.; Kosaka, Y. 1989: Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma Rinsho Byori. Japanese Journal of Clinical Pathology 37(2): 118-121
Sakon, M.; Monden, M.; Gotoh, M.; Kobayashi, K.; Kanai, T.; Umeshita, K.; Endoh, W.; Mori, T. 1991: The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma American Journal of Gastroenterology 86(3): 339-345
Hasegawa, Y.; Tomita, K.; Hashimoto, K.; Shigeoka, Y.; Watanabe, M.; Yamasaki, A.; Shimizu, E. 2005: Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation Anticancer Research 25(6c): 4569-4571
Tang, W.; Miki, K.; Kokudo, N.; Sugawara, Y.; Imamura, H.; Minagawa, M.; Yuan, L-Wen.; Ohnishi, S.; Makuuchi, M. 2003: Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma International Journal of Oncology 22(5): 969-975
Tsugawa, D.; Fukumoto, T.; Kido, M.; Takebe, A.; Tanaka, M.; Kuramitsu, K.; Matsumoto, I.; Ajiki, T.; Koyama, T.; Ku, Y. 2015: The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma Kobe journal of medical sciences 61(5): E124-E131
Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T. 1985: Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
Kamachi, S.; Sakurabayashi, I.; Kawai, T. 1984: Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer Rinsho Byori. Japanese Journal of Clinical Pathology 32(7): 781-785
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Marth, C.; Fuith, L.C.; Böck, G.; Daxenbichler, G.; Dapunt, O. 1989: Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon Cancer Research 49(23): 6538-6542